Loading...
BCL9L
The protein is a transcriptional regulator that acts as an activator. It promotes beta-catenin transcriptional activity and plays a role in tumorigenesis. It also enhances the neoplastic transforming activity of CTNNB1.
Protein class
Cancer-related genes
Predicted location
Intracellular
Single cell type specificity
Cell type enhanced (Glandular and luminal cells)
Immune cell specificity
Not detected in immune cells
Cell line specificity
Low cell line specificity
Interaction
Found in a complex with CDC73; CTNNB1 and PYGO1. Interacts with CTNNB1.
Molecular function
Activator
More Types Infomation
- Recombinant Human Anti-BCL9L Soluble TCR (KH9) (ZIP-Fos/ZIP-Jun) (VS-0622-YF1418)
-
- Epitope: FVYVFITHL
- MHC: HLA-A2
- Recombinant Human Anti-BCL9L Soluble TCR (LE5) (ZIP-Fos/ZIP-Jun) (VS-0622-YF1417)
-
- Species Reactivity: Human
- Epitope: FVYVFTTHL
- MHC: HLA-A2
- Recombinant Human Anti-BCL9L Soluble TCR (KH9) (C-Cys) (VS-0622-YF4126)
-
- Epitope: FVYVFITHL
- MHC: HLA-A2
- Recombinant Human Anti-BCL9L Soluble TCR (LE5) (C-Cys) (VS-0622-YF4125)
-
- Species Reactivity: Human
- Epitope: FVYVFTTHL
- MHC: HLA-A2
- Human Anti-BCL9L Recombinant Soluble TCR (clone KH9) (scTCR-0117YC-S(P))
-
- Epitope: FVYVFITHL
- MHC: HLA-A2
- Human Anti-BCL9L Recombinant Soluble TCR (clone LE5) (scTCR-0116YC-S(P))
-
- Species Reactivity: Human
- Epitope: FVYVFTTHL
- MHC: HLA-A2
- Recombinant Human Anti-BCL9L Soluble TCR (KH9) (KIH) (VS-0622-YF6834)
-
- Epitope: FVYVFITHL
- MHC: HLA-A2
- Recombinant Human Anti-BCL9L Soluble TCR (LE5) (KIH) (VS-0622-YF6833)
-
- Species Reactivity: Human
- Epitope: FVYVFTTHL
- MHC: HLA-A2
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
For Research Use Only. Not For Clinical Use.